Dr. Ginsberg serves as director of the Cancer Survivorship Program at Children’s Hospital of Philadelphia and has a robust research program on survivorship and fertility preservation for cancer patients.
Dr. Emanuel investigates diseases caused by abnormalities of human chromosome 22. These include the most common microdeletion syndrome, 22q11.2 deletion syndrome, and the most common recurrent constitutional translocation in humans, the t(11;22). Her efforts include discerning the mechanisms involved in generating the deletion and translocation as well as looking for modifiers of the phenotype in individuals with the deletion syndrome.
Goli Mostoufi-Moab, MD, MSCE, a dual-certified pediatric oncologist and endocrinologist at CHOP, has taken the lead to study endocrinopathies, affecting up to 40 to 60 percent of childhood cancer survivors.
The good news is that more children survive cancer now than ever before, with doctors able to cure nearly 80 percent of patients. But that doesn't mean that kids who survive cancer stop fighting once their treatment ends, because many face a variety of physical and emotional challenges as a result of their treatment.